Inactivation of Purified Human Recombinant Monoamine Oxidases A and B by Rasagiline and Its Analogues
- 27 February 2004
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 47 (7) , 1760-1766
- https://doi.org/10.1021/jm0310885
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Crystal Structures of Monoamine Oxidase B in Complex with Four Inhibitors of theN-Propargylaminoindan ClassJournal of Medicinal Chemistry, 2004
- Limited potentiation of blood pressure response to oral tyramine by brain-selective monoamine oxidase A-B inhibitor, TV-3326 in conscious rabbitsNeuropharmacology, 2002
- Novel Dual Inhibitors of AChE and MAO Derived from Hydroxy Aminoindan and Phenethylamine as Potential Treatment for Alzheimer's DiseaseJournal of Medicinal Chemistry, 2002
- Structure of human monoamine oxidase B, a drug target for the treatment of neurological disordersNature Structural & Molecular Biology, 2001
- Rasagiline [N‐propargyl‐1R(+)‐aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase BBritish Journal of Pharmacology, 2001
- High-Level Expression of Human Liver Monoamine Oxidase B in Pichia pastorisProtein Expression and Purification, 2000
- Effect of Deprenyl on the Progression of Disability in Early Parkinson's DiseaseNew England Journal of Medicine, 1989
- Structure of Flavin Adducts with Acetylenic SubstratesEuropean Journal of Biochemistry, 1976
- The structure of the covalent adduct formed by the interaction of 3-dimethylamino-1-propyne and the flavine of mitochondrial amine oxidaseBiochemistry, 1976
- Mitochondrial Monoamine OxidasePublished by Elsevier ,1974